Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumorCOOPER, L. S; GILLETT, C. E; PATEL, N. K et al.Cancer. 1999, Vol 86, Num 10, pp 2053-2058, issn 0008-543XArticle

Cyclin D1 in breast cancerBARNES, D. M; GILLETT, C. E.Breast cancer research and treatment. 1998, Vol 52, Num 1-3, pp 1-15, issn 0167-6806Article

A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markersRAMACHANDRA, S; GILLETT, C. E; MILLIS, R. R et al.Virchows Archiv. 1996, Vol 429, Num 6, pp 371-376, issn 0945-6317Article

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breastGILLETT, C. E; MILES, D. W; RYDER, K et al.Journal of pathology. 2001, Vol 193, Num 4, pp 433-441, issn 0022-3417Article

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancerEDWARDS, S. M; DUNSMUIR, W. D; KELLY, J et al.International journal of cancer. 1998, Vol 78, Num 1, pp 1-7, issn 0020-7136Article

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinomaRASBRIDGE, S. A; GILLETT, C. E; SAMPSON, S. A et al.Journal of pathology. 1993, Vol 169, Num 2, pp 245-250, issn 0022-3417Article

S100 protein in human mammary tissue ― immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cellsGILLETT, C. E; BOBROW, L. G; MILLIS, R. R et al.Journal of pathology. 1990, Vol 160, Num 1, pp 19-24, issn 0022-3417, 6 p.Article

Multiple tissue core arrays in histopathology research: a validation studyGILLETT, C. E; SPRINGALL, R. J; BARNES, D. M et al.Journal of pathology. 2000, Vol 192, Num 4, pp 549-553, issn 0022-3417Article

Cell proliferation measured by MIB1 and timing of surgery for breast cancerCOOPER, L. S; GILLETT, C. E; SMITH, P et al.British journal of cancer. 1998, Vol 77, Num 9, pp 1502-1507, issn 0007-0920Article

Retinoblastoma and p16 proteins in mammary carcinoma : Their relationship to cyclin D1 and histopathological parametersDUBLIN, E. A; PATEL, N. K; GILLETT, C. E et al.International journal of cancer. 1998, Vol 79, Num 1, pp 71-75, issn 0020-7136Article

Problems with p53 immunohistochemical staining : the effect of fixation and variation in the methods of evaluationFISHER, C. J; GILLETT, C. E; VOJTESEK, B et al.British journal of cancer. 1994, Vol 69, Num 1, pp 26-31, issn 0007-0920Article

Different patterns of inflammation and prognosis in invasive carcinoma of the breastLEE, A. H. S; GILLETT, C. E; RYDER, K et al.Histopathology. 2006, Vol 48, Num 6, pp 692-701, issn 0309-0167, 10 p.Article

A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cellsQIAO LIN, C; SINGH, J; MURATA, K et al.Cancer research (Baltimore). 2000, Vol 60, Num 5, pp 1332-1340, issn 0008-5472Article

Cyclin-dependent kinase inhibitor p27^Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinomaGILLETT, C. E; SMITH, P; PETERS, G et al.Journal of pathology. 1999, Vol 187, Num 2, pp 200-206, issn 0022-3417Article

Effect of c-erbB₂ and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracilMILES, D. W; HARRIS, W. H; GILLETT, C. E et al.International journal of cancer. 1999, Vol 84, Num 4, pp 354-359, issn 0020-7136Article

β1 and β4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breastHANBY, A. M; GILLETT, C. E; PIGNATELLI, M et al.Journal of pathology. 1993, Vol 171, Num 4, pp 257-262, issn 0022-3417Article

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections : an index of cell proliferation with evidence of deregulated expression in some neoplasmsHALL, P. A; LEVISON, D. A; WASEEM, N. H et al.Journal of pathology. 1990, Vol 162, Num 4, pp 285-294, issn 0022-3417Article

Use of a BRCA1 peptide validates MS110 as a BRCA1-specific antibody in immunohistochemistryALAMSHAH, A; SPRINGALL, R; GILLETT, C. E et al.Histopathology. 2008, Vol 53, Num 1, pp 117-120, issn 0309-0167, 4 p.Article

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breastFULFORD, L. G; EASTON, D. F; REIS-FILHO, J. S et al.Histopathology. 2006, Vol 49, Num 1, pp 22-34, issn 0309-0167, 13 p.Article

Mitotic counts provide additional prognostic information in grade II mammary carcinomaLYNCH, J; PATTEKAR, R; BARNES, D. M et al.Journal of pathology. 2002, Vol 196, Num 3, pp 275-279, issn 0022-3417Article

Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breastLEONG, A. C. K; HANBY, A. M; POTTS, H. W. W et al.International journal of cancer. 2000, Vol 89, Num 1, pp 26-31, issn 0020-7136Article

Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinomaGILLETT, C. E; BARNES, D. M; CAMPLEJOHN, R. S et al.Journal of clinical pathology. 1993, Vol 46, Num 12, pp 1126-1128, issn 0021-9746Article

Abnormal expression of wild type p53 protein in normal cells of a cancer family patientBARNES, D. M; HANBY, A. M; BARTEK, J et al.Lancet (British edition). 1992, Vol 340, Num 8814, pp 259-263, issn 0140-6736Article

BRCA1 dysfunction in sporadic basal-like breast cancerTURNER, N. C; REIS-FILHO, J. S; TUTT, A. N et al.Oncogene (Basingstoke). 2007, Vol 26, Num 14, pp 2126-2132, issn 0950-9232, 7 p.Article

Molecular markers for predicting prostate cancer stage and survivalDUNSMUIR, W. D; GILLETT, C. E; MEYER, L. C et al.BJU international (Papier). 2000, Vol 86, Num 7, pp 869-878, issn 1464-4096Article